PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12234789-6	2002	Treatment of OLETF rats with candesartan, an AT(1) receptor blocker, inhibited vascular expressions of VEGF, HIF-1alpha, and AGEs, and ameliorated the morphometric changes.	candesartan	29-40	vascular endothelial growth factor A	Rattus norvegicus	103-107	
25160895-10	2014	Interestingly, animals treated with both candesartan and l-dopa displayed significantly lower levels of VEGF, IL-1beta and dyskinesia than those treated with l-dopa alone.	candesartan	41-52	vascular endothelial growth factor A	Rattus norvegicus	104-108	
24681872-0	2014	Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.	candesartan	0-11	vascular endothelial growth factor A	Rattus norvegicus	149-192	
24681872-7	2014	A single candesartan dose induced a prolonged proangiogenic effect and a prolonged upregulation of VEGF-A and VEGF-B in vivo.	candesartan	9-20	vascular endothelial growth factor A	Rattus norvegicus	99-105	
25084762-9	2015	The expression of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) and its receptor was significantly increased in the animals treated with candesartan.	candesartan	178-189	vascular endothelial growth factor A	Rattus norvegicus	18-52	
25084762-9	2015	The expression of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) and its receptor was significantly increased in the animals treated with candesartan.	candesartan	178-189	vascular endothelial growth factor A	Rattus norvegicus	54-58	
18853323-4	2008	We also evaluated the effect of an ARB (2.5 mg/kg/day candesartan) or angiotensin II (500 ng/kg/min) on retinal gene expressions of VEGF and p22phox, a subunit of NADPH oxidase.	candesartan	54-65	vascular endothelial growth factor A	Rattus norvegicus	132-136	
18853323-8	2008	At 50 weeks, significant increases in VEGF and p22phox, an NADPH oxidase subunit, were significantly reduced by candesartan.	candesartan	112-123	vascular endothelial growth factor A	Rattus norvegicus	38-42